药物基因组学：预示了充满希望的未来以及回顾性的临床试验设计，FDA可能会为实现管理型决策的目的而批准后者。
Pharmacogenomics: Delivering on the Promise considers prospective versus retrospective clinical trial design and when, if ever, the FDA might allow the latter for regulatory decision-making purposes.
本文介绍了药物基因组学的概念、研究内容和方法及其在临床个体化用药中的应用及意义。
The article introduced the concept, content, methods of pharmacogenomics and its applications in establishing clinical individualized medication.
药物基因组学在临床药物治疗学和新药开发中具有重要的意义。
Pharmacogenomics plays an important role in clinical pharmaceutics and new drug research and development.
目的介绍药物基因组学及其在临床制定治疗方案中的应用。
Objective To introduce pharmacogenomics and its applications to establishing clinical pharmacotherapeutic schemes.
在药物基因组学，临床生物信息学由生物信息学工具和药物靶点的鉴定、临床验证相关的蛋白质组学等多方面研究组成。
In pharmacogenomics, clinical bioinformatics includes elaborate studies of bioinformatics tools and various facets of proteomics related to drug target identification and clinical validation.
方法阅读并分析近年国内公开发表的有关药物基因组学的相关文章，对药物基因组学在指导临床个体化用药方面的作用加以归纳、总结。
Methods to read and analyze published in recent years, the domestic pharmacogenomics related article on pharmacogenomics in guiding the clinical role of individual drugs to be summarized, summary.
方法阅读并分析近年国内公开发表的有关药物基因组学的相关文章，对药物基因组学在指导临床个体化用药方面的作用加以归纳、总结。
Methods to read and analyze published in recent years, the domestic pharmacogenomics related article on pharmacogenomics in guiding the clinical role of individual drugs to be summarized, summary.
应用推荐